Oncotelic Therapeutics, Inc. Stock Split Ratio
Oncotelic Therapeutics, Inc. (OTLC) reported Stock Split Ratio of 8.30% for the 1-month period ending 2012-12-31, per its 10-K filed 2014-03-20.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2014-03-20
- 2012-12-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 8.30%.
- 2012-12-28: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 8.30%.
- 2011-02-28: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 5.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|
| 2012-12-31 | 8.30% 10-K · filed 2014-03-20 |
| 2012-12-28 | 8.30% 10-Q · filed 2013-08-12 |
| 2011-02-28 | 5.00% 10-K · filed 2014-03-20 |